Private Harbour Investment Management & Counsel’s NovoCure NVCR Stock Holding History

Private Harbour Investment Management & Counsel’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,414	Closed	-$474K	–	44
2023 Q2	$474K	Sell	11,414 -513	-4%	-$31.9K	0.53%	40
2023 Q1	$717K	Sell	11,927 -358	-3%	-$28.6K	0.81%	34
2022 Q4	$901K	Sell	12,285 -146	-1%	-$11K	0.99%	35
2022 Q3	$945K	Sell	12,431 -675	-5%	-$52.7K	1.1%	35
2022 Q2	$911K	Sell	13,106 -157	-1%	-$11.8K	1.01%	37
2022 Q1	$1.1M	Sell	13,263 -299	-2%	-$22K	0.92%	39
2021 Q4	$1.02M	Buy	+13,562	New	+$1.36M	0.81%	42

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Private Harbour Investment Management & Counsel's NVCR Position: Q3 2023 in Review

Private Harbour Investment Management & Counsel sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 11,414 shares — an estimated $474K sold.

Private Harbour Investment Management & Counsel first reported a position in NVCR in Q4 2021 and held it in 7 quarters. The position peaked at $1.1M in Q1 2022. 227 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

Private Harbour Investment Management & Counsel reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
Private Harbour Investment Management & Counsel sold 11,414 NovoCure shares in Q3 2023, an estimated $474K.
Private Harbour Investment Management & Counsel first reported a position in NovoCure in Q4 2021 and held it in 7 quarters.
Private Harbour Investment Management & Counsel's NovoCure position peaked at $1.1M in Q1 2022.
227 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Private Harbour Investment Management & Counsel's 13F filing for Q3 2023, filed 31 Oct 2023.